Kenworthy Capital Shows Early Returns and Continues to Grow With a Focus on Giving Back

BOSTON, Aug. 1, 2019 /PRNewswire-PRWeb/ -- Impact investment funds are a unique form of financial investments that have been designed to balance out corporate social responsibility with financial gain for the investor. In light of the funding deficit in autoimmune disease research and the immediate attention required to reverse the effects of climate change, Kenworthy Capital has recently been launched to raise funds for the two movements.

Although still in its nascent stages, Kenworthy Capital has outperformed market indexes by offering returns as high as 60% this early in its lifetime. As a testament to their commitment the company is currently donating a percentage of the income to celiac disease research. Many agree with the goals of the investment fund, grateful to have the opportunity to become part of two of the biggest challenges faced by modern society.

When asked for a comment, Randal Kenworthy had this to offer:

"When the decision to form Kenworthy Capital was finalized, we weren't sure how many people would get behind the values we represented. Auto-immune disease research is under-funded at the moment and climate change reversal is a long-term effort. But much to our surprise and gratitude, we've had a lot of interest in Kenworthy Capital and we're glad to be delivering back to them while at the same time offering them the opportunity to become part of something greater."

In a time when many were wondering if it was possible for private investors to provide active support to humanitarian goals, Kenworthy Capital is testament to the willingness to work towards social benefit. With the efforts on part of the team at Kenworthy Capital, it seems clear that impact-investment has the potential to turn the tide against the advance of auto-immune diseases and the climate crisis.

It's projects like Kenworthy Capital, that combine financial innovation and embody the values of common good that are needed to help overcome the challenges that humanity faces. Facing these challenges will require large-scale research mobilization that Kenworthy Capital is trying to amass.

About Kenworthy Capital
Kenworthy Capital is an early stage impact investment fund that caters to climate change and auto-immune disease research. Contributing a part of incomes to either of these movements, Kenworthy Capital balances out financial returns with awareness efforts for the environment and public health.

Contact Information:
Website: https://www.randalkenworthy.com/
Email: kenworthycapital(at)gmail.com

SOURCE Kenworthy Capital